Clinical Study

Comparison of the Clinical Outcomes between Echelette Extended Range of Vision and Diffractive Bifocal Intraocular Lenses

Table 3

Visual acuities and refractive outcomes 3 months after IOL implantation.

ZXR00 (eyes = 45)ZMB00 (eyes = 34) value

UCDVA (logMAR), mean ± SD0.10 ± 0.130.19 ± 0.190.012
UCIVA (logMAR), mean ± SD0.15 ± 0.130.29 ± 0.17<0.001
UCNVA (logMAR), mean ± SD0.35 ± 0.190.26 ± 0.210.057
CDVA (logMAR), mean ± SD−0.01 ± 0.070.03 ± 0.080.008
CIVA (logMAR), mean ± SD0.03 ± 0.110.08 ± 0.150.134
CNVA (logMAR), mean ± SD0.10 ± 0.200.10 ± 0.180.719
DCIVA (logMAR), mean ± SD0.12 ± 0.130.32 ± 0.19<0.001
DCNVA (logMAR), mean ± SD0.38 ± 0.170.22 ± 0.240.001
Int SE add (D), mean ± SD0.72 ± 0.520.94 ± 0.380.036
Near SE add (D), mean ± SD1.84 ± 0.620.45 ± 1.14<0.001
SE (D), mean ± SD−0.22 ± 0.610.12 ± 0.730.025

UCDVA = uncorrected distance visual acuity; UCIVA = uncorrected intermediate visual acuity; UCNVA = uncorrected near visual acuity; CDVA = corrected distance visual acuity; CIVA = corrected intermediate visual acuity; CNVA = corrected near visual acuity; DCIVA = distance-corrected intermediate visual acuity; DCNVA = distance-corrected near visual acuity; SE = spherical equivalent; int SE add = addition of diopters to spectacle from the best corrected distance vision to achieve the best corrected intermediate vision; near SE add = addition of diopters to spectacle from the best corrected distance vision to achieve the best corrected near vision; D = diopter; SD = standard deviation.